EndoChoice
A platform-technology firm, provides devices, diagnostics and infection control for treating gastrointestinal diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€191m (Public information from Nov 2016)
Alpharetta Georgia (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Series A | ||
| N/A | $3.2m | Early VC | |
| N/A | $7.8m | Early VC | |
| N/A | $4.5m | Early VC | |
* | N/A | - | |
$43.0m | Late VC | ||
$57.0m | Series D | ||
| N/A | N/A | IPO | |
$210m Valuation: $210m | Acquisition | ||
| Total Funding | €105m | ||
Recent News about EndoChoice
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.